Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

Louise de Swart, Alex Smith, Marius MacKenzie, Argiris Symeonidis, Judith Neukirchen, Dana Mikulenková, Teresa Vallespí, Gina Zini, Malgorzata Paszkowska-Kowalewska, Anton Kruger, Leonie Saft, Pierre Fenaux, David Bowen, Eva Hellström-Lindberg, Jaroslav Čermák, Reinhard Stauder, Aurelia Tatic, Mette Skov Holm, Luca Malcovati, Krzysztof MądryJackie Droste, Nicole Blijlevens, Theo de Witte, Ulrich Germing

Research output: Contribution to journalArticle

Abstract

The European LeukemiaNet MDS (EUMDS) registry is collecting data of myelodysplastic syndrome (MDS) patients belonging to the IPSS low or intermediate-1 category, newly diagnosed by local cytologists. The diagnosis of MDS can be challenging, and some data report inter-observer variability with regard to the assessment of the MDS subtype. In order to ensure that correct diagnoses were made by the participating centres, blood and bone marrow slides of 10% of the first 1000 patients were reviewed by an 11-person panel of cytomorphologists. All slides were rated by at least 3 panel members (median 8 panel members; range 3–9). Marrow slides from 98 out of 105 patients were of good quality and therefore could be rated properly according to the WHO 2001 classification, including assessment of dysplastic lineages. The agreement between the reviewers whether the diagnosis was MDS or non-MDS was strong with an intra-class correlation coefficient (ICC) of 0.85. Six cases were detected not to fit the entry criteria of the registry, because they were diagnosed uniformly as CMML or AML by the panel members. The agreement by WHO 2001 classification was strong as well (ICC = 0.83). The concordance of the assessment of dysplastic lineages was substantial for megakaryopoiesis and myelopoiesis and moderate for erythropoiesis. Our data show that in general, the inter-observer agreement was high and a very low percentage of misdiagnosed cases had been entered into the EUMDS registry. Further studies including histomorphology are warranted.

Original languageEnglish
Pages (from-to)1105-1112
Number of pages8
JournalAnnals of Hematology
Volume96
Issue number7
DOIs
Publication statusPublished - Jul 1 2017

Fingerprint

Myelodysplastic Syndromes
Registries
Bone Marrow
Myelopoiesis
Observer Variation
Erythropoiesis
Diagnostic Errors

Keywords

  • Cytomorphology review
  • Diagnostics
  • Inter-observer variability
  • Myelodysplastic syndromes (MDS)

ASJC Scopus subject areas

  • Hematology

Cite this

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance. / de Swart, Louise; Smith, Alex; MacKenzie, Marius; Symeonidis, Argiris; Neukirchen, Judith; Mikulenková, Dana; Vallespí, Teresa; Zini, Gina; Paszkowska-Kowalewska, Malgorzata; Kruger, Anton; Saft, Leonie; Fenaux, Pierre; Bowen, David; Hellström-Lindberg, Eva; Čermák, Jaroslav; Stauder, Reinhard; Tatic, Aurelia; Holm, Mette Skov; Malcovati, Luca; Mądry, Krzysztof; Droste, Jackie; Blijlevens, Nicole; de Witte, Theo; Germing, Ulrich.

In: Annals of Hematology, Vol. 96, No. 7, 01.07.2017, p. 1105-1112.

Research output: Contribution to journalArticle

de Swart, L, Smith, A, MacKenzie, M, Symeonidis, A, Neukirchen, J, Mikulenková, D, Vallespí, T, Zini, G, Paszkowska-Kowalewska, M, Kruger, A, Saft, L, Fenaux, P, Bowen, D, Hellström-Lindberg, E, Čermák, J, Stauder, R, Tatic, A, Holm, MS, Malcovati, L, Mądry, K, Droste, J, Blijlevens, N, de Witte, T & Germing, U 2017, 'Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance', Annals of Hematology, vol. 96, no. 7, pp. 1105-1112. https://doi.org/10.1007/s00277-017-3009-7
de Swart, Louise ; Smith, Alex ; MacKenzie, Marius ; Symeonidis, Argiris ; Neukirchen, Judith ; Mikulenková, Dana ; Vallespí, Teresa ; Zini, Gina ; Paszkowska-Kowalewska, Malgorzata ; Kruger, Anton ; Saft, Leonie ; Fenaux, Pierre ; Bowen, David ; Hellström-Lindberg, Eva ; Čermák, Jaroslav ; Stauder, Reinhard ; Tatic, Aurelia ; Holm, Mette Skov ; Malcovati, Luca ; Mądry, Krzysztof ; Droste, Jackie ; Blijlevens, Nicole ; de Witte, Theo ; Germing, Ulrich. / Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance. In: Annals of Hematology. 2017 ; Vol. 96, No. 7. pp. 1105-1112.
@article{d28df4bba9a144ef8243494114521406,
title = "Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance",
abstract = "The European LeukemiaNet MDS (EUMDS) registry is collecting data of myelodysplastic syndrome (MDS) patients belonging to the IPSS low or intermediate-1 category, newly diagnosed by local cytologists. The diagnosis of MDS can be challenging, and some data report inter-observer variability with regard to the assessment of the MDS subtype. In order to ensure that correct diagnoses were made by the participating centres, blood and bone marrow slides of 10{\%} of the first 1000 patients were reviewed by an 11-person panel of cytomorphologists. All slides were rated by at least 3 panel members (median 8 panel members; range 3–9). Marrow slides from 98 out of 105 patients were of good quality and therefore could be rated properly according to the WHO 2001 classification, including assessment of dysplastic lineages. The agreement between the reviewers whether the diagnosis was MDS or non-MDS was strong with an intra-class correlation coefficient (ICC) of 0.85. Six cases were detected not to fit the entry criteria of the registry, because they were diagnosed uniformly as CMML or AML by the panel members. The agreement by WHO 2001 classification was strong as well (ICC = 0.83). The concordance of the assessment of dysplastic lineages was substantial for megakaryopoiesis and myelopoiesis and moderate for erythropoiesis. Our data show that in general, the inter-observer agreement was high and a very low percentage of misdiagnosed cases had been entered into the EUMDS registry. Further studies including histomorphology are warranted.",
keywords = "Cytomorphology review, Diagnostics, Inter-observer variability, Myelodysplastic syndromes (MDS)",
author = "{de Swart}, Louise and Alex Smith and Marius MacKenzie and Argiris Symeonidis and Judith Neukirchen and Dana Mikulenkov{\'a} and Teresa Vallesp{\'i} and Gina Zini and Malgorzata Paszkowska-Kowalewska and Anton Kruger and Leonie Saft and Pierre Fenaux and David Bowen and Eva Hellstr{\"o}m-Lindberg and Jaroslav Čerm{\'a}k and Reinhard Stauder and Aurelia Tatic and Holm, {Mette Skov} and Luca Malcovati and Krzysztof Mądry and Jackie Droste and Nicole Blijlevens and {de Witte}, Theo and Ulrich Germing",
year = "2017",
month = "7",
day = "1",
doi = "10.1007/s00277-017-3009-7",
language = "English",
volume = "96",
pages = "1105--1112",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

AU - de Swart, Louise

AU - Smith, Alex

AU - MacKenzie, Marius

AU - Symeonidis, Argiris

AU - Neukirchen, Judith

AU - Mikulenková, Dana

AU - Vallespí, Teresa

AU - Zini, Gina

AU - Paszkowska-Kowalewska, Malgorzata

AU - Kruger, Anton

AU - Saft, Leonie

AU - Fenaux, Pierre

AU - Bowen, David

AU - Hellström-Lindberg, Eva

AU - Čermák, Jaroslav

AU - Stauder, Reinhard

AU - Tatic, Aurelia

AU - Holm, Mette Skov

AU - Malcovati, Luca

AU - Mądry, Krzysztof

AU - Droste, Jackie

AU - Blijlevens, Nicole

AU - de Witte, Theo

AU - Germing, Ulrich

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The European LeukemiaNet MDS (EUMDS) registry is collecting data of myelodysplastic syndrome (MDS) patients belonging to the IPSS low or intermediate-1 category, newly diagnosed by local cytologists. The diagnosis of MDS can be challenging, and some data report inter-observer variability with regard to the assessment of the MDS subtype. In order to ensure that correct diagnoses were made by the participating centres, blood and bone marrow slides of 10% of the first 1000 patients were reviewed by an 11-person panel of cytomorphologists. All slides were rated by at least 3 panel members (median 8 panel members; range 3–9). Marrow slides from 98 out of 105 patients were of good quality and therefore could be rated properly according to the WHO 2001 classification, including assessment of dysplastic lineages. The agreement between the reviewers whether the diagnosis was MDS or non-MDS was strong with an intra-class correlation coefficient (ICC) of 0.85. Six cases were detected not to fit the entry criteria of the registry, because they were diagnosed uniformly as CMML or AML by the panel members. The agreement by WHO 2001 classification was strong as well (ICC = 0.83). The concordance of the assessment of dysplastic lineages was substantial for megakaryopoiesis and myelopoiesis and moderate for erythropoiesis. Our data show that in general, the inter-observer agreement was high and a very low percentage of misdiagnosed cases had been entered into the EUMDS registry. Further studies including histomorphology are warranted.

AB - The European LeukemiaNet MDS (EUMDS) registry is collecting data of myelodysplastic syndrome (MDS) patients belonging to the IPSS low or intermediate-1 category, newly diagnosed by local cytologists. The diagnosis of MDS can be challenging, and some data report inter-observer variability with regard to the assessment of the MDS subtype. In order to ensure that correct diagnoses were made by the participating centres, blood and bone marrow slides of 10% of the first 1000 patients were reviewed by an 11-person panel of cytomorphologists. All slides were rated by at least 3 panel members (median 8 panel members; range 3–9). Marrow slides from 98 out of 105 patients were of good quality and therefore could be rated properly according to the WHO 2001 classification, including assessment of dysplastic lineages. The agreement between the reviewers whether the diagnosis was MDS or non-MDS was strong with an intra-class correlation coefficient (ICC) of 0.85. Six cases were detected not to fit the entry criteria of the registry, because they were diagnosed uniformly as CMML or AML by the panel members. The agreement by WHO 2001 classification was strong as well (ICC = 0.83). The concordance of the assessment of dysplastic lineages was substantial for megakaryopoiesis and myelopoiesis and moderate for erythropoiesis. Our data show that in general, the inter-observer agreement was high and a very low percentage of misdiagnosed cases had been entered into the EUMDS registry. Further studies including histomorphology are warranted.

KW - Cytomorphology review

KW - Diagnostics

KW - Inter-observer variability

KW - Myelodysplastic syndromes (MDS)

UR - http://www.scopus.com/inward/record.url?scp=85019754420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019754420&partnerID=8YFLogxK

U2 - 10.1007/s00277-017-3009-7

DO - 10.1007/s00277-017-3009-7

M3 - Article

C2 - 28526957

AN - SCOPUS:85019754420

VL - 96

SP - 1105

EP - 1112

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 7

ER -